Foundation for Women’s Cancer | Strategic Alliance Partners

home / partners / organizations / foundation-for-womens-cancer

KidneyCAN is a nonprofit organization with a mission to accelerate cures for kidney cancer through education, advocacy, and research funding.

Latest from Foundation for Women’s Cancer

Next-generation clinical trials may address when to use CDK4/6 inhibition in patients with low-grade serous ovarian cancer.

Exploring CDK4/6 Endocrine Therapy for Low-Grade Serous Ovarian Cancer

Kathleen N. Moore, MD, MS

February 27th 2025

Next-generation clinical trials may address when to use CDK4/6 inhibition in patients with low-grade serous ovarian cancer.

The NRG-GY019 trial will assess chemotherapy plus letrozole vs letrozole alone as a frontline treatment for patients with low-grade serous ovarian cancer.

Evaluating Frontline Treatment Options for Low-Grade Serous Ovarian Cancer

Kathleen N. Moore, MD, MS

February 26th 2025

The NRG-GY019 trial will assess chemotherapy plus letrozole vs letrozole alone as a frontline treatment for patients with low-grade serous ovarian cancer.

Nearly 40% of low-grade serous ovarian cancers have RAS alterations, which are predominately KRAS mutations.

Distinguishing Low-Grade Serous Ovarian Cancer From Other Ovarian Cancer Types

Kathleen N. Moore, MD, MS

February 25th 2025

Nearly 40% of low-grade serous ovarian cancers have RAS alterations, which are predominately KRAS mutations.

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777